Ian McElree

Vanderbilt University Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Jacob Taylor

NYU Langone Health

UNITED STATES

View details

Vignesh Packiam

Associate Professor of Urology

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

Michael O'Donnell

Harvard University

UNITED STATES

View details

Yousef Zakharia

The University of Iowa

UNITED STATES

View details

Ryan Steinberg

Clinical Assistant Professor

University of Iowa Healthcare

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ian McElree

Research Interests

Explore related searches

Contact this professor

Articles (10)

The role of blue light cystoscopy and additional operative evaluations during first surveillance after induction therapy for high-risk NMIBC

Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel – does time from transurethral resection of bladder tumour to induction matter?

Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor

Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer

Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma

Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette–Guérin for the treatment of upper tract carcinoma in situ

Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma.

Alternative Instillation Techniques of Sequential Intravesical Gemcitabine and Docetaxel for NMIBC.

Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated intermediate-risk nonmuscle invasive bladder cancer

Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancer

Collaborators (5)

Jacob Taylor

Vignesh Packiam

Michael O'Donnell

Yousef Zakharia

Ryan Steinberg

Make your next move.